Change in composition of high density lipoprotein during gemfibrozil therapy
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 67 (2-3) , 181-189
- https://doi.org/10.1016/0021-9150(87)90278-4
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteinsPublished by American Medical Association (AMA) ,1985
- Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in manPublished by American Medical Association (AMA) ,1984
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983
- Gemfibrozil in the Treatment of Dyslipidaemia A 5‐year follow‐up studyActa Medica Scandinavica, 1982
- Plasma Prekallikrein, Kallikrein Inhibitors, Kininogen and Lipids during Gemfibrozil Treatment in Type II DyslipidaemiaActa Medica Scandinavica, 1982
- Gemfibrozil in the Treatment of Dyslipidaemias in Middle‐Aged Male Survivors of Myocardial InfarctionActa Medica Scandinavica, 1981
- Normalization of Triglycerides in Type IV Hyperlipoproteinemia Fails to Correct Low Levels of High-Density-Lipoprotein CholesterolNew England Journal of Medicine, 1980
- Stimulation and suppression of 3-hydroxy-3-methylglutaryl coenzyme a reductase in normal human fibroblasts by high density lipoprotein subclassesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- H.D.L. CHOLESTEROL: THE VARIABLE COMPONENTSThe Lancet, 1978
- Serum high density lipoprotein in diabetic patientsDiabetologia, 1977